XNAS · BGLC
-8.29% · -$0.1600 · Vol 5.2K
Market closed · last close 4:00 PM ET · price as of 16:18:58 ET
BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp Common stock

SERVICES-MEDICAL LABORATORIES
$1.77
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BGLC moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for BGLC are being assembled.
About BioNexus Gene Lab Corp Common stock
SERVICES-MEDICAL LABORATORIES
Listed since
2020
Employees
1
Country
US

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.92
Day high
$1.92
Day low
$1.73
Previous close
$1.93
52W high
$2.69
-34.20% from high
52W low
$1.73
4% of range
Market cap
$4.7M
EPS
$-0.9980
Shares out
2.4M
Volume
5.2K
VWAP
$1.81
Price history computed in-house
1W
-8.29%
1M
-8.05%
SMA 50 $2.14 · below
SMA 200 $2.14 · below
52W position 4%
Veridion warehouse edge

Warehouse intelligence for BGLC.

Veridion Score
40
0: 951: 442: 343: 204: Not reported5: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BGLC insider activity

BioNexus Gene Lab Corp Common stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for BGLC.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BGLC contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BGLC in this window.
Lobbying spend

BGLC lobbying filings, year to date.

Registered lobbying filings matched to BioNexus Gene Lab Corp Common stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BGLC in this window.
Latest news · BGLC
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BGLC.
Options
Sovereign unlock shows live options positioning for BGLC.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.